IDH2 MUTATION

Clinical trials for IDH2 MUTATION explained in plain language.

Never miss a new study

Get alerted when new IDH2 MUTATION trials appear

Sign up with your email to follow new studies for IDH2 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for AML patients: gentler drug combo could replace harsh chemo

Disease control Not yet recruiting

This study compares a new drug combination (venetoclax plus azacitidine) against standard chemotherapy for adults with a specific type of acute myeloid leukemia (AML) that has NPM1 or IDH mutations. About 148 people will be randomly assigned to one of the two treatments. The main…

Matched conditions: IDH2 MUTATION

Phase: PHASE2 • Sponsor: Shen yang • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

IDH2 MUTATION

Get alerted when new IDH2 MUTATION trials appear

New hope for AML patients: gentler drug combo could replace harsh chemo